These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43. Proceedings for the 5th workshop for the Biochemical and Pharmacological Research on Affective Disorders. May 26-27, 1989, Tokyo. Jpn J Psychiatry Neurol; 1990 Mar; 44(1):123-57. PubMed ID: 2362387 [No Abstract] [Full Text] [Related]
44. The structure of psychopharmacological revolutions. Healy D Psychiatr Dev; 1987; 5(4):349-76. PubMed ID: 3328200 [TBL] [Abstract][Full Text] [Related]
45. Research strategies in the investigation of the indoleamine hypothesis of affective illness. Bunney WE Adv Biochem Psychopharmacol; 1982; 34():247-8. PubMed ID: 6215835 [No Abstract] [Full Text] [Related]
46. Antidepressants, catecholamines and 5-hydroxyindoles. Trends towards a more specific research in the field of antidepressants. Van Praag HM Psychiatr Neurol Neurochir; 1967; 70(3):219-33. PubMed ID: 4861203 [No Abstract] [Full Text] [Related]
47. The catecholamine hypothesis of affective disorders: a review of supporting evidence. 1965. Schildkraut JJ J Neuropsychiatry Clin Neurosci; 1995; 7(4):524-33; discussion 523-4. PubMed ID: 8555758 [No Abstract] [Full Text] [Related]
48. Glucocorticoid-biogenic amine interactions in relation to mood and behavior. McEwen BS Biochem Pharmacol; 1987 Jun; 36(11):1755-63. PubMed ID: 3555503 [No Abstract] [Full Text] [Related]
49. Biogenic amines and emotion. Schildkraut JJ; Kety SS Science; 1967 Apr; 156(3771):21-37. PubMed ID: 5335690 [TBL] [Abstract][Full Text] [Related]
51. The catecholamine hypothesis of affective disorders: a review of supporting evidence. Schildkraut JJ Am J Psychiatry; 1965 Nov; 122(5):509-22. PubMed ID: 5319766 [No Abstract] [Full Text] [Related]
52. Antidepressants and convulsive seizures: clinical, electroencephalographic, and pharmacological aspects. Edwards JG; Long SK; Sedgwick EM; Wheal HV Clin Neuropharmacol; 1986; 9(4):329-60. PubMed ID: 3524821 [No Abstract] [Full Text] [Related]
53. Temperature and pulse chronomes in patients with neurotic and affective disorders treated with some antidepressants and tranquillizers. Madjirova N Folia Med (Plovdiv); 1997; 39(2):71-7. PubMed ID: 9314670 [TBL] [Abstract][Full Text] [Related]
54. Involvement of the central serotonergic system in affective illness. Kalin NH; Risch SC; Murphy DL J Clin Psychopharmacol; 1981 Jul; 1(4):232-7. PubMed ID: 7028804 [TBL] [Abstract][Full Text] [Related]
56. The catecholamine hypothesis of affective disorders. A review of supporting evidence. Schildkraut JJ Int J Psychiatry; 1967 Sep; 4(3):203-17. PubMed ID: 4863731 [No Abstract] [Full Text] [Related]
57. Blood platelets as a model system for studying serotonergic dysfunction and effects of antidepressants. Lingjaerde O Pharmacol Toxicol; 1990; 66 Suppl 3():61-8. PubMed ID: 2179932 [No Abstract] [Full Text] [Related]
58. [Role of sugar in regulation of the diet]. Quaade F Tandlaegernes Tidsskr; 1990 Jul; 5(7):198-201. PubMed ID: 2397123 [No Abstract] [Full Text] [Related]
59. Current trends in Australian neurology. Selby G Postgrad Med J; 1970 Apr; 46(534):191-9. PubMed ID: 4316785 [No Abstract] [Full Text] [Related]
60. The role of calcium in the etiology of the affective disorders. Helmeste DM; Tang SW Jpn J Pharmacol; 1998 Jun; 77(2):107-16. PubMed ID: 9681567 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]